10X Genomics wins judgment against Vizgen's US antitrust counterclaims
MLex Summary: 10X Genomics was granted a summary judgment against Vizgen’s US claims accusing it of attempting to monopolize the market for single-cell spatial transcriptomics products. District Judge Matthew F. Kennelly said...To view the full article, register now.
Already a subscriber? Click here to view full article